All Articles on Vaccine
COVID-19 vaccine well tolerated, generates immune responseNational Institute of Allergy and Infectious Diseases-sponsored phase 1 trial tested mRNA vaccine.
5 questions with an influenza and COVID-19 epidemiologistDr. Mike Jackson has long studied the spread of flu and effectiveness of vaccination at Kaiser Permanente Washington. And now… of COVID-19 too.
Coronavirus vaccine trial now includes older peopleLed by Dr. Lisa A. Jackson, first-ever trial of any experimental vaccine candidate for COVID-19 virus has expanded.
Research versus COVID-19From clinical trials to technical support, Dr. Rita Mangione-Smith describes how Kaiser Permanente Washington researchers are fighting the novel coronavirus.
Kaiser Permanente launches first coronavirus vaccine trialOn March 16, 4 volunteers received an injection of an mRNA vaccine for COVID-19 in NIH-funded trial in Seattle.
Vaccines: Benefits outweigh the risksThe benefits of vaccines far outweigh the risks. Still, the debate about the value of vaccines continues on. Here are some facts to help you make the right health decision for your child.
Straight talk about vaccines for your young childThere’s a lot of information out there about the merits and risks of vaccines. Parents are rightly concerned about making the best choices for their children amid conflicting information.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.